| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9890 | 
      | Human Intestinal Absorption | HIA+ | 0.9934 | 
      | Caco-2 Permeability | Caco2+ | 0.7329 | 
      | P-glycoprotein Substrate | Substrate | 0.8872 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.9060 | 
                                                     | Inhibitor | 0.5000 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.6701 | 
        
            | Distribution | 
        
      | Subcellular localization | Plasma membrane | 0.4241 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8326 | 
      | CYP450 2D6 Substrate | Substrate | 0.6581 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5000 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.7998 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8897 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.9111 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.7202 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7461 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5400 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8688 | 
                                                                    | Inhibitor | 0.7855 | 
      | AMES Toxicity | Non AMES toxic | 0.8588 | 
      | Carcinogens | Non-carcinogens | 0.9160 | 
      | Fish Toxicity | High FHMT | 0.8578 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9189 | 
      | Honey Bee Toxicity | Low HBT | 0.7827 | 
      | Biodegradation | Not ready biodegradable | 0.9973 | 
      | Acute Oral Toxicity | III | 0.7708 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7563 |